LABP Landos Biopharma
- 22.4500
- +0.2450+1.10%
- 22.3900
- -0.0600-0.27%
Landos Biopharma News
Landos Biopharma Analyst Ratings
Maintaining Hold Rating on Landos Biopharma Amid Acquisition by AbbVie and Limited Upside Potential
Analysts Have Conflicting Sentiments on These Healthcare Companies: Arcellx Inc (ACLX), Afya (AFYA) and Landos Biopharma (LABP)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Pliant Therapeutics (PLRX) and Landos Biopharma (LABP)
Analysts Offer Insights on Healthcare Companies: Arcutis Biotherapeutics (ARQT), Deciphera Pharmaceuticals (DCPH) and Landos Biopharma (LABP)
Landos Biopharma (LABP) Receives a Rating Update From a Top Analyst
JonesTrading Reaffirms Their Hold Rating on Landos Biopharma (LABP)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Arcutis Biotherapeutics (ARQT), Landos Biopharma (LABP) and Theseus Pharmaceuticals (THRX)
Landos Biopharma Analyst Ratings
SVB Securities Sticks to Its Hold Rating for Landos Biopharma (LABP)
Landos Biopharma Analyst Ratings
SVB Leerink Maintains Market Perform on Landos Biopharma, Lowers Price Target to $2
Landos Biopharma (LABP) Receives a Hold From JonesTrading
SVB Securities Keeps Their Hold Rating on Landos Biopharma (LABP)
Landos Biopharma Is Maintained at Market Perform by SVB Leerink
SVB Leerink Maintains Market Perform on Landos Biopharma, Lowers Price Target to $3
Landos Biopharma Cut to Market Perform From Outperform by Raymond James
Landos Biopharma analyst ratings
Analysis
Price Target
No Data
